2.Study on Watering Extraction Process of Yangyinqingwei Oral Liquid
Huaiqing WEN ; Wenchao HUANG ; Bin LI
China Pharmacy 1991;0(06):-
OBJECTIVE:To select the optimum watering extraction process of yangyinqingwei oral liquid. METHODS: Influence of extraction time upon the extraction of volatile oil was observed; The orthogonal design was adopted to observe the extraction process of weight of the extracts and the content of paeoniflorin. RESULTS & CONCLUSIONS:The optimum watering extraction process of yangyinqingwei oral liquid was that medicinal materials were dipped for 30 minutes before decoction,then the extraction of volatile oil in saposhnikovia divaricata and pogostemon cablinlasted for 2 hours, next the residue of drugs and the other drugs were decocted together, and finally water of 8 times as much as the drugs were added and the mixture was extracted 3 times, with 1.5 hours for each time.
3.Clinicopathologic characteristics of primary squamous cell carcinoma of the breast
Shunhai JIAN ; Bin WEN ; Yifan HUANG
Cancer Research and Clinic 2010;22(3):161-163,167
Objective To investigate the clinicopathologic and immunohistochemicalcharacteristics of primary squamous cell carcinoma of the breast(PSCCB). Methods Sixteen patients with primary squamous cell carcinoma of the breast were retrospectively reviewed. Twelve cases with a follow-up information were evaluated for ER, PR, C-erbB-2, HCK, Ki-67 expression. Results PSCCB is a very rare neoplasm,constituting 0.8 % of all breast carcinoma over 28 years(1981-2008) in our hospital. The patients age varied from 25 to 72, median age is 49 years old. All patients received operative treatment. Seven patients had metastatic disease in axillary lymph nodes. Three patients died from metastases and tumour recurrence.Tumors were usually ER-negative, but most cases showed high molecular cytokeratin (HCK) expression.Conclusion In terms of the clinical feature, there were no differences between the PSCCB and the other breast cancer. PSCCB could be confirmed by pathology. The prognosis is in controversial. Standard therapy should be studied and recommended in future.
4.IgG4-related sclerosing diseases.
Chinese Journal of Pathology 2008;37(2):135-138
5.Recent advances in pathology and molecular genetics of small cell carcinoma of the urinary bladder.
Liang CHENG ; Wen-bin HUANG ; Jie CHEN
Chinese Journal of Pathology 2007;36(10):700-703
Biomarkers, Tumor
;
metabolism
;
Carcinoma, Small Cell
;
genetics
;
metabolism
;
pathology
;
Carcinoma, Squamous Cell
;
pathology
;
Chromosome Aberrations
;
Diagnosis, Differential
;
Humans
;
Keratins
;
metabolism
;
Lymphoma
;
pathology
;
Mucin-1
;
metabolism
;
Urinary Bladder
;
pathology
;
Urinary Bladder Neoplasms
;
genetics
;
metabolism
;
pathology
6.“Identification Card”:Sites on Histone Modification of Cancer Cell
Chinese Medical Sciences Journal 2015;(4):203-209
Formation of malignant tumor originating from normal healthy cell is a multistep process including genetic and epigenetic lesions. Previous studies of cell line model systems displayed that early important epigenetic events happened in stepwise fashion prior to cell immortalization. Once these epigenetic alterations are integrated into chromatin, they will perform vertical propagation through cell subculture. Hence, status of epigenetics is dramatically important in maintaining of cell identity. Histone modification is another factor of epigenetic alterations during human oncogenesis. Histones, one of main components of chromatin, can be modified post-translationally. Histone tail modifications are regulated by corresponding modification enzymes. This review focuses on the description of relationship between the main sites of histone modification and oncogenesis.
7.Recent advance in staging of prostate cancer.
Liang CHENG ; Qiu RAO ; Wen-bin HUANG
Chinese Journal of Pathology 2013;42(5):351-354
Humans
;
International Agencies
;
Lymph Nodes
;
pathology
;
Lymphatic Metastasis
;
Male
;
Neoplasm Invasiveness
;
Neoplasm Staging
;
methods
;
Prostate-Specific Antigen
;
metabolism
;
Prostatic Neoplasms
;
pathology
;
Seminal Vesicles
;
pathology
;
Societies, Medical
;
Tumor Burden
;
United States
;
Urinary Bladder
;
pathology
8.Intraoperative radiotherapy using low-energy X rays:dosimetric characteristics and potential limitations in clinical application
Bin OUYANG ; Zhenhua XIAO ; Zhenyu WANG ; Botian HUANG ; Bixiu WEN
Chinese Journal of Radiation Oncology 2016;25(8):867-871
Objective To test intraoperative radiotherapy with mobile photon beam using the INTRABEAM system ( Germany) , and to analyze the dosimetric characteristics of low?energy photon beam using X?ray source and spherical applicators and explore its potential limitations in clinical application. Methods A special water phantom, a parallel?plate ionization chamber, and an electrometer were used to measure the depth dose rates and isotropy of dose distribution in x/y plane of X?ray source and different spherical applicators in the INTRABEAM system. Those data were then compared with the system data. Results For the X?ray source, the deviation of observed depth dose rate and isotropy in the x/y plane from the system data were-2.16%± 1. 36% and-1.9%~ 2. 1%, respectively. For applicators with different diameters, the deviation of observed depth dose rate, transfer coefficient, and isotropy in x/y plane from the system data were-10.0%~2. 3%,-8.9%~4. 2%, and-1.6%~2. 6%, respectively. Surface dose rate and dose gradient became larger with the decrease in the diameter of the spherical applicator. The measurement of depth dose rate and isotropy of X?ray source and spherical applicators showed good repeatability. The influencing factors for measurement accuracy included the positioning error of ionization chamber, energy response, noise current, and correction factor f ’ ( R ) . Conclusions This study reveals the dosimetric characteristics of the INTRABEAM system, verifies the accuracy of the system data, and obtains the data for clinical application and routine quality assurance. However, large dose gradient and small therapeutic range may limit its wide clinical application.
9.Preparation of the Compound Chlorhexidine Acetate Ear Drops
Daoqiu HUANG ; Weiya FENG ; Bilong WEN ; Bin ZHANG ; Wanming CHEN
China Pharmacy 2001;0(07):-
OBJECTIVE:To prepare the compound chlorhexidine acetate ear drops for treating anaerobic and aerobic infections of antrum auris METHODS:The compound chlorhexidine acetate ear drops was prepared with mixed solvent of glycerin,alcohol and distilled water The contents of two main ingredients were determined by dual-wavelength isobestic point spectrophotometry and the stability of preparation was examined RESULTS:The average recovery of metronidazole was 99 34%(RSD=0 57%,n=6) and that of chlorhexidine acetate was 101 17%(RSD=0 88%,n=6) CONCLUSION:The new preparation is rational in formula,simple in quality control and good in stability and has good prospects in development
10.Cloning Chitinase Gene of the Entomopathogene Fungus Metarhizium anisopliae HN1 and High-level Expression in Escherichia coli
Wen-Bin REN ; Shi-Qing ZHANG ; Jun-Sheng HUANG ;
China Biotechnology 2006;0(07):-
Chitinases genes from Metarhizium anisopliae which is an important entomopathogenic fungus were considered one of the key factors to invade their hosts. One Metarhizium anisopliae HN1 strain was isolated and screened. A chitinase gene was amplified by RT-PCR from Metarhizium anisopliae HN1, The whole length of this gene was 1275bp,and the nucleotide sequence of the gene was 96% similarity to that of the M. anisopliae E6 accessed in GenBank ( AF02749). The gene has been registered in GenBank and its accession number is DQ011865. The gene was subcloned into prokaryon expression vector pET-22b( + ), transformed this recombinant expression plasmid into E. coli strain BL 21 and effective expressed. The SDS-PAGE analysis indicated that the recombinant protein was 42kDa which is same to the reported article. The expression level of recombinant protein was about 63. 3% of whole expressed proteins , And when recombinant E. coli were crushed by freeze and supersonic wave , the activity assay indicates that the chitinase expressed in bacteria possesses biological activity.